Cargando…
Senolytic treatment reduces oxidative protein stress in an aging male murine model of post‐traumatic osteoarthritis
Senolytic drugs are designed to selectively clear senescent cells (SnCs) that accumulate with injury or aging. In a mouse model of osteoarthritis (OA), senolysis yields a pro‐regenerative response, but the therapeutic benefit is reduced in aged mice. Increased oxidative stress is a hallmark of advan...
Autores principales: | Chin, Alexander F., Han, Jin, Clement, Cristina C., Choi, Younghwan, Zhang, Hong, Browne, Maria, Jeon, Ok Hee, Elisseeff, Jennifer H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652304/ https://www.ncbi.nlm.nih.gov/pubmed/37749958 http://dx.doi.org/10.1111/acel.13979 |
Ejemplares similares
-
Senolytic drugs relieve pain by reducing peripheral nociceptive signaling without modifying joint tissue damage in spontaneous osteoarthritis
por: Gil, Tae-Hwan, et al.
Publicado: (2022) -
Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy
por: Nogueira-Recalde, Uxía, et al.
Publicado: (2019) -
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
por: Raman, Deepika, et al.
Publicado: (2023) -
Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020)